A Study to Assess the Drug-drug Interaction of BMS-963272 and Rosuvastatin

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Healthy participants, as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations * Women must not be of childbearing potential (WNOCBP) * Women and men must agree to follow instructions for methods of contraception Exclusion Criteria: * Any significant acute or chronic medical condition that presents a potential risk to the participant and/or may compromise the objectives of the study. * Any major surgery within 4 weeks of study drug administration * Any blood transfusion or donation of blood to a blood bank or in a clinical study within 4 weeks of study drug administration * Previous treatment with BMS-963272 * Participants who smoke, as well as, those who have stopped smoking less than 6 months prior to day 1 Other protocol-defined inclusion/exclusion criteria could apply